Clinical Trial Update: Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating post-meal insulin dosing with an adjuvant pre-meal pramlintide in children with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Pramlintide (Symlin) (pramlintide)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2018-07-10